Public consultation

Public consultation is part of the EUCAST decision process. The consultation period is 4 - 12 weeks, and the dates of the beginning and end of the period is clearly stated.

Previous public consultations with comments and EUCAST responses

Proposed new breakpoints for amphotericin B, three echinocandins and flucytosine against Candida auris. Public consultation 6 March - 17 April 2025. Comments and EUCAST AFST responses (17 June 2025)

The subcommittee on antifungal susceptibility testing (the EUCAST AFST) revised breakpoints and rationale documents as a consequece of the EUCAST change in the definition of the I-category and the introduction of ATU (Consultations of antifungal revised breakpoints and RDs 25 Sept- 15 Nov, 2019):
1. Amphotericin B
2. Anidulafungin
3. Fluconazole
4. Isavuconazole
5. Itraconazole
6. Micafungin
7. Posaconazole
8. Voriconazole
9. AFST Breakpoint table v. 10
Comments and EUCAST AFST response to consultation.
The proposed revision of voriconazole breakpoints (15 December, 2017). There were no comments and the changes were implemented following the end of the consultation period.

Contact

Looking for more information? Get in touch with an EUCAST representative today!

Contact form